ZA200205193B - Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. - Google Patents

Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.

Info

Publication number
ZA200205193B
ZA200205193B ZA200205193A ZA200205193A ZA200205193B ZA 200205193 B ZA200205193 B ZA 200205193B ZA 200205193 A ZA200205193 A ZA 200205193A ZA 200205193 A ZA200205193 A ZA 200205193A ZA 200205193 B ZA200205193 B ZA 200205193B
Authority
ZA
South Africa
Prior art keywords
dimethylaminomethyl
hydroxycyclohexyl
hydroxybenzoate
phenyl
esters derived
Prior art date
Application number
ZA200205193A
Other languages
English (en)
Inventor
Juan Huguet Clotet
Marisabel Mourelle Mancini
Elisabet De Ramon Amat
Original Assignee
Vita Invest Sa
Merger Lab Vita S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa, Merger Lab Vita S A filed Critical Vita Invest Sa
Publication of ZA200205193B publication Critical patent/ZA200205193B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200205193A 1999-12-30 2002-06-27 Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl. ZA200205193B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.

Publications (1)

Publication Number Publication Date
ZA200205193B true ZA200205193B (en) 2003-06-27

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205193A ZA200205193B (en) 1999-12-30 2002-06-27 Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.

Country Status (30)

Country Link
US (1) US6894076B2 (sh)
EP (1) EP1251120B1 (sh)
JP (1) JP2003519208A (sh)
KR (1) KR20020063281A (sh)
CN (1) CN1414946A (sh)
AP (1) AP1234A (sh)
AT (1) ATE284380T1 (sh)
AU (1) AU775918B2 (sh)
BG (1) BG106883A (sh)
BR (1) BR0016882A (sh)
CA (1) CA2395976A1 (sh)
CZ (1) CZ20022189A3 (sh)
DE (1) DE60016631D1 (sh)
EA (1) EA004770B1 (sh)
EE (1) EE200200365A (sh)
ES (1) ES2160534B1 (sh)
HR (1) HRP20020559A2 (sh)
HU (1) HUP0204147A3 (sh)
IL (1) IL150392A0 (sh)
IS (1) IS6440A (sh)
MA (1) MA26862A1 (sh)
MX (1) MXPA02006514A (sh)
NO (1) NO20023098D0 (sh)
NZ (1) NZ520263A (sh)
OA (1) OA12132A (sh)
PL (1) PL356056A1 (sh)
SK (1) SK9252002A3 (sh)
WO (1) WO2001049650A1 (sh)
YU (1) YU50902A (sh)
ZA (1) ZA200205193B (sh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
EP2273983B1 (en) 2008-05-09 2016-07-20 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
PL2456427T3 (pl) 2009-07-22 2015-07-31 Gruenenthal Gmbh Wytłaczana na gorąco postać dawki o kontrolowanym uwalnianiu
PL2456424T3 (pl) 2009-07-22 2013-12-31 Gruenenthal Gmbh Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EA201401139A1 (ru) 2012-04-18 2015-03-31 Грюненталь Гмбх Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
DK3354649T3 (da) 2015-10-15 2020-02-24 Jiangsu Hengrui Medicine Co Oxaspiroderivat, fremstillingsmetode derfor og anvendelser deraf i lægemidler

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
MA26862A1 (fr) 2004-12-20
AP1234A (en) 2003-12-28
MXPA02006514A (es) 2004-07-30
HUP0204147A3 (en) 2003-10-28
NO20023098L (no) 2002-06-26
EA200200614A1 (ru) 2002-12-26
BG106883A (en) 2003-05-30
AU2012601A (en) 2001-07-16
YU50902A (sh) 2006-01-16
CZ20022189A3 (cs) 2003-03-12
JP2003519208A (ja) 2003-06-17
US6894076B2 (en) 2005-05-17
NO20023098D0 (no) 2002-06-26
ATE284380T1 (de) 2004-12-15
WO2001049650A1 (es) 2001-07-12
IL150392A0 (en) 2002-12-01
HRP20020559A2 (en) 2004-02-29
PL356056A1 (en) 2004-06-14
ES2160534A1 (es) 2001-11-01
EE200200365A (et) 2003-10-15
NZ520263A (en) 2004-07-30
SK9252002A3 (en) 2003-04-01
BR0016882A (pt) 2002-11-05
CA2395976A1 (en) 2001-07-12
OA12132A (en) 2006-05-05
IS6440A (is) 2002-06-25
KR20020063281A (ko) 2002-08-01
EA004770B1 (ru) 2004-08-26
DE60016631D1 (de) 2005-01-13
EP1251120B1 (en) 2004-12-08
AU775918B2 (en) 2004-08-19
US20030100598A1 (en) 2003-05-29
CN1414946A (zh) 2003-04-30
AP2002002571A0 (en) 2002-09-30
ES2160534B1 (es) 2002-04-16
HUP0204147A2 (hu) 2003-04-28
EP1251120A1 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
ZA200205193B (en) Novel esters derived from (RR,SS)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl.
HK1048122A1 (en) Method for the preparation of citalopram.
IL160081A0 (en) Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
ZA200108855B (en) Method for the preparation of citalopram.
HK1049002A1 (en) Method for the preparation of citalopram.
IL143868A0 (en) Use of 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylene -delta 3-dihydrofurane-2-on for controlling the white fly
ZA200108248B (en) Antiperspirant compositions.
AU2001290642A1 (en) Vectors derived from south african arbovirus no. 86
EG23909A (en) Vatamin d, analogs
AU6432800A (en) Process for the synthesis of citalopram
HK1042246A1 (en) Controlled-release compositions of betahistine.
AU2224100A (en) Conga shell protector
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AU2001251321A1 (en) Vancomycin analogs
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
MXPA02000261A (es) Aminoindanos novedosos.
HK1051179A1 (en) Prostaglandin e analogues.
GB0029650D0 (en) Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters
MXPA03005965A (es) Composicion farmaceutica que contiene citalopram.
AU2003223098A1 (en) Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
AU7512400A (en) Hardness stabilization by mercaptopyridines
FR2789448B1 (fr) Helice, notamment pour groupe moto-ventilateur
ZA200201714B (en) Novel compound F-15078.
AU3158801A (en) Novel vaccine composition